Lauren Dewlin, PA
Physician Assistant · Sparks, MDNPI 1265738660
Payments from drug & device makers
Across 172 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$852
- AbbVie$465
- Sun Pharmaceutical Industries Inc.$266
- Novartis$196
- Sanofi$178
- Regeneron Healthcare Solutions, Inc.$163
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,73587%
- Education$40113%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 58 | $852 |
| AbbVie | 24 | $465 |
| Sun Pharmaceutical Industries Inc. | 10 | $266 |
| Novartis | 8 | $196 |
| Sanofi | 6 | $178 |
| Regeneron Healthcare Solutions, Inc. | 5 | $163 |
| Dermavant Sciences, Inc. | 19 | $154 |
| Organon | 6 | $94 |
| LEO Pharma Inc. | 5 | $90 |
| UCB, Inc. | 3 | $83 |
| Pfizer | 3 | $81 |
| Lilly USA, LLC | 3 | $75 |
| E.r. Squibb & Sons, L.L.C. | 4 | $74 |
| Incyte Corporation | 4 | $71 |
| Galderma Laboratories, L.p. | 3 | $63 |
| Arcutis Biotherapeutics, Inc. | 3 | $60 |
| Journey Medical Corporation | 2 | $59 |
| Almirall LLC | 2 | $45 |
| Amgen | 2 | $40 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,136 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $88,550 |
| Clobetasol Propionate | 93 | $6,603 |
| Tacrolimus | 17 | $3,174 |
| Metronidazole | 36 | $1,989 |
| Betamethasone Dipropionate | 39 | $1,970 |
| Ketoconazole | 79 | $1,804 |
| Triamcinolone Acetonide | 180 | $1,572 |
| Fluocinonide | 27 | $1,522 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 26 | $1,169 |
| Clindamycin Phosphate | 27 | $993 |
| Doxycycline Hyclate | 48 | $898 |
| Tretinoin | 20 | $882 |
| Ciclopirox | 13 | $551 |
| Doxycycline Monohydrate | 13 | $517 |
| ValacyclovirValacyclovir Hcl | 21 | $427 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Sparks
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
- Shannon MarriottBaltimore$38K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.